Physician profile
Roy Moreira
NPI 1457351918
$12,726.12
in general payments reported to CMS, 2019-2025
47 companies · $1,578 in 2025
The $1,578 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,264 · 2020: $1,817 · 2021: $2,596 · 2022: $2,290 · 2023: $1,984 · 2024: $1,198 · 2025: $1,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,485 · Consulting Fee: $175 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,484.86 |
| Consulting Fee | $175.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,786.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,767.88 | 2019-2025 | Farxiga, Breztri |
| Abbvie INC. | $1,504.23 | 2019-2025 | |
| Lilly USA, LLC | $1,123.72 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $725.22 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $605.40 | 2019-2024 | Verquvo, Belsomra, Steglatro |
| Abbott Laboratories | $589.95 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Bayer Healthcare Pharmaceuticals INC. | $554.94 | 2021-2024 | |
| Amgen INC. | $544.27 | 2019-2025 | Prolia, Repatha, Evenity |
| Sanofi-Aventis U.S. LLC | $502.42 | 2019-2023 | |
| Esperion Therapeutics, INC. | $305.33 | 2020-2024 | Nexletol |
| Janssen Pharmaceuticals, INC | $252.92 | 2019-2022 | |
| Amarin Pharma, INC. | $217.09 | 2019-2021 | |
| Eisai INC. | $196.88 | 2020-2021 | |
| Exact Sciences Corporation | $163.98 | 2024-2025 | Cologuard Collection Kit |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Moreira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.